Recently, Sun et al. [20] demonstrated that miR-195 was a potent suppressor of YAP1 which can be potential therapeutic targets as the chief downstream effectors of the Hippo pathway in a variety of cancers [21, 22]. Here, YAP1 is linked to cancer.